Unified Patent Court (UPC) analytics are now available. Check here

EP3009143

NEURODYN LIFE SCIENCES
Application Number
EP15194111A
Filing Date
Jan 16, 2009
Status
Revoked
Jul 7, 2023
Grant Date
Oct 3, 2018
External Links
Slate, Register, Google Patents

Biblio Summary

The patent EP3009143B1 was granted on Oct 3, 2018 by Neurodyn Life Sciences The patent is currently Revoked.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

CMS CAMERON MCKENNA NABARRO OLSWANGJul 3, 2019ADMISSIBLE
MATHYS & SQUIREJul 2, 2019ADMISSIBLE

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionEP2687223B2
N/A
OppositionUS2005123962
N/A
OppositionWO2008019187
N/A
OppositionWO2007146046
N/A
OppositionWO2009010045
N/A
OppositionWO2008079187
N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.